|
|
thymocyte apoptotic process
|
GO:0070242 |
2 |
0.519
|
|
|
|
positive regulation of apoptotic process involved in morphogenesis
|
GO:1902339 |
1 |
0.424
|
|
|
|
neuron death in response to oxidative stress
|
GO:0036475 |
9 |
0.359
|
|
|
|
patterning of blood vessels
|
GO:0001569 |
2 |
0.250
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.227
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.200
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.186
|
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.176
|
|
|
|
regulation of apoptotic process involved in morphogenesis
|
GO:1902337 |
1 |
0.174
|
|
|
|
positive regulation of calcium ion transport into cytosol
|
GO:0010524 |
20 |
0.158
|
|
|
|
post embryonic organ development
|
GO:0048569 |
1 |
0.155
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.151
|
|
|
|
mitochondrial fusion
|
GO:0008053 |
13 |
0.151
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.150
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.148
|
|
|
|
liposaccharide metabolic process
|
GO:1903509 |
27 |
0.145
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
3 |
0.145
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.142
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.141
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
82 |
0.141
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
33 |
0.139
|
|
|
|
blood vessel remodeling
|
GO:0001974 |
2 |
0.138
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.127
|
|
|
|
regulation of sequestering of calcium ion
|
GO:0051282 |
41 |
0.127
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.125
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.125
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.121
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.119
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
67 |
0.119
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
47 |
0.118
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.117
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.115
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.115
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.114
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.111
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.110
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.109
|
|
|
|
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
|
GO:0001844 |
2 |
0.107
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.106
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.104
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.100
|
|
|
|
tissue homeostasis
|
GO:0001894 |
63 |
0.097
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.096
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
102 |
0.095
|
|
|
|
regulation of developmental pigmentation
|
GO:0048070 |
2 |
0.094
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.093
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.092
|
|
|
|
response to salt stress
|
GO:0009651 |
3 |
0.092
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.091
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
79 |
0.091
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.087
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.087
|
|
|
|
negative regulation of endoplasmic reticulum calcium ion concentration
|
GO:0032471 |
6 |
0.087
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
51 |
0.087
|
|
|
|
monovalent inorganic cation homeostasis
|
GO:0055067 |
37 |
0.087
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.086
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
26 |
0.086
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.085
|
|
|
|
regulation of cellular ph
|
GO:0030641 |
17 |
0.081
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
101 |
0.081
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.081
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.080
|
|
|
|
glycolipid metabolic process
|
GO:0006664 |
27 |
0.079
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.079
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.078
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.078
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
3 |
0.077
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.077
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.076
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.073
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.072
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.072
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.071
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
74 |
0.071
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.071
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.070
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.070
|
|
|
|
hypothalamus development
|
GO:0021854 |
1 |
0.070
|
|
|
|
positive regulation of endoplasmic reticulum unfolded protein response
|
GO:1900103 |
4 |
0.069
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
17 |
0.069
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.068
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.068
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.065
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
90 |
0.065
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
120 |
0.065
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.065
|
|
|
|
cytokinesis
|
GO:0000910 |
96 |
0.065
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
24 |
0.065
|
|
|
|
negative regulation of binding
|
GO:0051100 |
57 |
0.065
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.065
|
|
|
|
dna catabolic process
|
GO:0006308 |
49 |
0.065
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.064
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.063
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.062
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.062
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.061
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.061
|
|
|
|
regulation of release of sequestered calcium ion into cytosol
|
GO:0051279 |
27 |
0.061
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.060
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.060
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.059
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
68 |
0.059
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.059
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.058
|
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
26 |
0.058
|
|
|
|
kidney development
|
GO:0001822 |
53 |
0.057
|
|
|
|
tissue remodeling
|
GO:0048771 |
16 |
0.057
|
|
|
|
t cell homeostasis
|
GO:0043029 |
3 |
0.057
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.056
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.056
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
82 |
0.056
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.056
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.056
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.055
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
122 |
0.055
|
|
|
|
ovulation cycle
|
GO:0042698 |
9 |
0.055
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
87 |
0.055
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.054
|
|
|
|
response to cocaine
|
GO:0042220 |
1 |
0.054
|
|
|
|
regulation of mononuclear cell proliferation
|
GO:0032944 |
65 |
0.054
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.054
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.053
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.053
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.052
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
43 |
0.052
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
38 |
0.052
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.051
|
|
|
|
male gonad development
|
GO:0008584 |
23 |
0.051
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.051
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.051
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.051
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.050
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
158 |
0.050
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.050
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
89 |
0.050
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.050
|
|
|
|
protein insertion into mitochondrial membrane
|
GO:0051204 |
3 |
0.049
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.049
|
|
|
|
apoptotic nuclear changes
|
GO:0030262 |
13 |
0.049
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.049
|
|
|
|
regulation of oxidative stress induced cell death
|
GO:1903201 |
24 |
0.049
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.049
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
68 |
0.049
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.049
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.048
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
73 |
0.048
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.048
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.048
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.048
|
|
|
|
defense response to virus
|
GO:0051607 |
71 |
0.048
|
|
|
|
mitochondrial fission
|
GO:0000266 |
14 |
0.048
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.048
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.047
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.047
|
|
|
|
positive regulation of dna metabolic process
|
GO:0051054 |
73 |
0.047
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.047
|
|
|
|
cell death in response to oxidative stress
|
GO:0036473 |
29 |
0.047
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.047
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.046
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.045
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.045
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.045
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.045
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.045
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.045
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.044
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.044
|
|
|
|
interaction with host
|
GO:0051701 |
42 |
0.044
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.043
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
82 |
0.043
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.043
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.043
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.042
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.042
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.042
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
59 |
0.042
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.041
|
|
|
|
head development
|
GO:0060322 |
108 |
0.041
|
|
|
|
regulation of oxidative stress induced neuron death
|
GO:1903203 |
9 |
0.041
|
|
|
|
negative regulation of sequestering of calcium ion
|
GO:0051283 |
41 |
0.041
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
103 |
0.041
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.041
|
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.041
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.040
|
|
|
|
positive regulation of leukocyte activation
|
GO:0002696 |
80 |
0.040
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.040
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.040
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.040
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.039
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.039
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
70 |
0.039
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
85 |
0.039
|
|
|
|
b cell activation
|
GO:0042113 |
33 |
0.039
|
|
|
|
mitochondrial outer membrane permeabilization involved in programmed cell death
|
GO:1902686 |
16 |
0.039
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.038
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.038
|
|
|
|
response to axon injury
|
GO:0048678 |
1 |
0.038
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.038
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
4 |
0.038
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.038
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.038
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
64 |
0.038
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.037
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
110 |
0.037
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.037
|
|
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.037
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.037
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.037
|
|
|
|
single organism membrane fusion
|
GO:0044801 |
37 |
0.037
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.037
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.037
|
|
|
|
positive regulation of mononuclear cell proliferation
|
GO:0032946 |
47 |
0.036
|
|
|
|
positive regulation of cellular response to oxidative stress
|
GO:1900409 |
7 |
0.036
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.036
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.036
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
34 |
0.035
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.035
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
48 |
0.035
|
|
|
|
regulation of endoplasmic reticulum unfolded protein response
|
GO:1900101 |
5 |
0.035
|
|
|
|
fertilization
|
GO:0009566 |
12 |
0.035
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.035
|
|
|
|
response to topologically incorrect protein
|
GO:0035966 |
29 |
0.034
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.034
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.034
|
|
|
|
positive regulation of release of sequestered calcium ion into cytosol
|
GO:0051281 |
16 |
0.034
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.034
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
15 |
0.034
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.034
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.034
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.034
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.034
|
|
|
|
negative regulation of protein binding
|
GO:0032091 |
35 |
0.033
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.033
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.033
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.033
|
|
|
|
inner mitochondrial membrane organization
|
GO:0007007 |
8 |
0.033
|
|
|
|
female genitalia development
|
GO:0030540 |
2 |
0.033
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.033
|
|
|
|
response to unfolded protein
|
GO:0006986 |
24 |
0.033
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.033
|
|
|
|
female gonad development
|
GO:0008585 |
10 |
0.033
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.033
|
|
|
|
membrane fusion
|
GO:0061025 |
43 |
0.033
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.032
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.032
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
50 |
0.032
|
|
|
|
mononuclear cell proliferation
|
GO:0032943 |
71 |
0.032
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.032
|
|
|
|
zymogen activation
|
GO:0031638 |
70 |
0.032
|
|
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.031
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.031
|
|
|
|
mitochondrial fragmentation involved in apoptotic process
|
GO:0043653 |
7 |
0.031
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.031
|
|
|
|
response to ketone
|
GO:1901654 |
19 |
0.031
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.031
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.031
|
|
|
|
t cell proliferation
|
GO:0042098 |
45 |
0.031
|
|
|
|
regulation of protein binding
|
GO:0043393 |
66 |
0.031
|
|
|
|
cellular response to unfolded protein
|
GO:0034620 |
16 |
0.031
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
43 |
0.031
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.031
|
|
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
1 |
0.031
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.031
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.031
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
117 |
0.030
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.030
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.030
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.030
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
73 |
0.030
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.029
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
23 |
0.029
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.029
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.029
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.029
|
|
|
|
cellular response to topologically incorrect protein
|
GO:0035967 |
19 |
0.029
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
46 |
0.029
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.028
|
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
54 |
0.028
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
21 |
0.028
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.028
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.028
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.027
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.027
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
21 |
0.027
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.027
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.027
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.027
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.027
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.026
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.026
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
2 |
0.026
|
|
|
|
ovarian follicle development
|
GO:0001541 |
5 |
0.026
|
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.026
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.026
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
48 |
0.026
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.026
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.026
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.026
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.026
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.026
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
93 |
0.026
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.025
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.025
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
20 |
0.025
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.025
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.025
|
|
|
|
rhythmic process
|
GO:0048511 |
31 |
0.025
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.025
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.025
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.025
|
|
|
|
dna catabolic process endonucleolytic
|
GO:0000737 |
37 |
0.025
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.025
|
|
|
|
odontogenesis
|
GO:0042476 |
25 |
0.025
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.025
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001267 |
2 |
0.025
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.025
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.024
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.024
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.024
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.024
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.024
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.024
|
|
|
|
b cell homeostasis
|
GO:0001782 |
1 |
0.024
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.024
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.024
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.024
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.024
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.024
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.024
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.024
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
33 |
0.024
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
16 |
0.024
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
45 |
0.024
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
38 |
0.023
|
|
|
|
endoplasmic reticulum unfolded protein response
|
GO:0030968 |
16 |
0.023
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.023
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.023
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.023
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.023
|
|
|
|
female sex differentiation
|
GO:0046660 |
12 |
0.023
|
|
|
|
ovulation cycle process
|
GO:0022602 |
9 |
0.023
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.023
|
|
|
|
negative regulation of signal transduction in absence of ligand
|
GO:1901099 |
16 |
0.022
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.022
|
|
|
|
regulation of cellular ph reduction
|
GO:0032847 |
1 |
0.022
|
|
|
|
regulation of apoptotic dna fragmentation
|
GO:1902510 |
3 |
0.022
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
31 |
0.022
|
|
|
|
cellular response to uv
|
GO:0034644 |
32 |
0.022
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.022
|
|
|
|
response to alcohol
|
GO:0097305 |
64 |
0.022
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.022
|
|
|
|
response to uv
|
GO:0009411 |
73 |
0.022
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.022
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.022
|
|
|
|
activation of immune response
|
GO:0002253 |
114 |
0.022
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.022
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.021
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.021
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.021
|
|
|
|
positive regulation of mitochondrion organization
|
GO:0010822 |
30 |
0.021
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.021
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
70 |
0.021
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.021
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
61 |
0.021
|
|
|
|
negative regulation of response to dna damage stimulus
|
GO:2001021 |
33 |
0.020
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
38 |
0.020
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.020
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.020
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.020
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.020
|
|
|
|
cellular response to mechanical stimulus
|
GO:0071260 |
39 |
0.020
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
24 |
0.020
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001269 |
1 |
0.020
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.020
|
|
|
|
execution phase of apoptosis
|
GO:0097194 |
32 |
0.020
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.019
|
|
|
|
response to toxic substance
|
GO:0009636 |
37 |
0.019
|
|
|
|
regulation of mitochondrial membrane potential
|
GO:0051881 |
23 |
0.019
|
|
|
|
er nucleus signaling pathway
|
GO:0006984 |
23 |
0.019
|
|
|
|
positive regulation of response to oxidative stress
|
GO:1902884 |
7 |
0.019
|
|
|
|
pigmentation
|
GO:0043473 |
22 |
0.019
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.019
|
|
|
|
establishment or maintenance of transmembrane electrochemical gradient
|
GO:0010248 |
2 |
0.019
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.019
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
32 |
0.019
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.019
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.019
|
|
|
|
regulation of protein homodimerization activity
|
GO:0043496 |
9 |
0.019
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.019
|
|
|
|
regulation of mitochondrial membrane permeability involved in apoptotic process
|
GO:1902108 |
18 |
0.019
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
97 |
0.019
|
|
|
|
positive regulation of dna catabolic process
|
GO:1903626 |
2 |
0.019
|
|
|
|
neuron death
|
GO:0070997 |
65 |
0.019
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.019
|
|
|
|
cerebral cortex development
|
GO:0021987 |
10 |
0.019
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.018
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
20 |
0.018
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process by cytochrome c
|
GO:0008635 |
2 |
0.018
|
|
|
|
regulation of protein localization to plasma membrane
|
GO:1903076 |
40 |
0.018
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.018
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.018
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.018
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.018
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
52 |
0.018
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.018
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.018
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.018
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.018
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.018
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
21 |
0.018
|
|
|
|
response to mechanical stimulus
|
GO:0009612 |
51 |
0.017
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.017
|
|
|
|
t cell apoptotic process
|
GO:0070231 |
12 |
0.017
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.017
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.017
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.017
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.017
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.017
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.017
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.017
|
|
|
|
positive regulation of mitochondrial membrane permeability involved in apoptotic process
|
GO:1902110 |
16 |
0.017
|
|
|
|
response to gamma radiation
|
GO:0010332 |
14 |
0.017
|
|
|
|
mitochondrial membrane organization
|
GO:0007006 |
40 |
0.017
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.017
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
39 |
0.017
|
|
|
|
behavioral defense response
|
GO:0002209 |
0 |
0.017
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.017
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.017
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.017
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.017
|
|
|
|
male sex differentiation
|
GO:0046661 |
25 |
0.017
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.017
|
|
|
|
thymus development
|
GO:0048538 |
3 |
0.016
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.016
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.016
|
|
|
|
cellular response to light stimulus
|
GO:0071482 |
34 |
0.016
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.016
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.016
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.016
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.016
|
|
|
|
cellular component disassembly involved in execution phase of apoptosis
|
GO:0006921 |
13 |
0.016
|
|
|
|
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
|
GO:0070059 |
12 |
0.016
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
57 |
0.016
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.016
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.016
|
|
|
|
cellular monovalent inorganic cation homeostasis
|
GO:0030004 |
26 |
0.016
|
|
|
|
growth
|
GO:0040007 |
202 |
0.015
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.015
|
|
|
|
regulation of ph
|
GO:0006885 |
20 |
0.015
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.015
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
23 |
0.015
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
19 |
0.015
|
|
|
|
necrotic cell death
|
GO:0070265 |
21 |
0.015
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
42 |
0.015
|
|
|
|
programmed necrotic cell death
|
GO:0097300 |
18 |
0.015
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
32 |
0.015
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.015
|
|
|
|
mammary gland involution
|
GO:0060056 |
1 |
0.015
|
|
|
|
regulation of protein heterodimerization activity
|
GO:0043497 |
5 |
0.015
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.015
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.015
|
|
|
|
positive regulation of oxidative stress induced intrinsic apoptotic signaling pathway
|
GO:1902177 |
4 |
0.014
|
|
|
|
limb development
|
GO:0060173 |
23 |
0.014
|
|
|
|
eye development
|
GO:0001654 |
42 |
0.014
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.014
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
49 |
0.014
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.014
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.014
|
|
|
|
organelle fusion
|
GO:0048284 |
36 |
0.014
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
10 |
0.014
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.014
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
22 |
0.014
|
|
|
|
response to nicotine
|
GO:0035094 |
12 |
0.014
|
|
|
|
mitochondrion morphogenesis
|
GO:0070584 |
8 |
0.014
|
|
|
|
telencephalon development
|
GO:0021537 |
17 |
0.014
|
|
|
|
ph reduction
|
GO:0045851 |
11 |
0.014
|
|
|
|
negative regulation of establishment of protein localization to plasma membrane
|
GO:0090005 |
9 |
0.014
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.013
|
|
|
|
positive regulation of developmental pigmentation
|
GO:0048087 |
2 |
0.013
|
|
|
|
transformed cell apoptotic process
|
GO:0006927 |
3 |
0.013
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.013
|
|
|
|
response to transition metal nanoparticle
|
GO:1990267 |
29 |
0.013
|
|
|
|
regulation of neuron death
|
GO:1901214 |
56 |
0.013
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.013
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.013
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.013
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
37 |
0.013
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.013
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.013
|
|
|
|
negative regulation of protein localization to plasma membrane
|
GO:1903077 |
13 |
0.013
|
|
